Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists

Int J Dermatol. 2012 Oct;51(10):1234-6. doi: 10.1111/j.1365-4632.2011.05166.x. Epub 2012 Mar 14.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acitretin / adverse effects
  • Acitretin / therapeutic use
  • Adalimumab
  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Dermatologic Agents / therapeutic use
  • Etanercept
  • Humans
  • Immunoglobulin G / adverse effects
  • Immunoglobulin G / therapeutic use
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Male
  • Melanoma / diagnosis*
  • Melanoma / etiology*
  • Melanoma / pathology
  • Methotrexate / therapeutic use
  • Psoriasis / drug therapy
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Severity of Illness Index
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / etiology*
  • Skin Neoplasms / pathology
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Cyclosporine
  • Infliximab
  • Adalimumab
  • Acitretin
  • Etanercept
  • Methotrexate